JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 17, 2004; DOI: 10.1124/jpet.104.079608


0022-3565/05/3131-154-164$20.00
JPET 313:154-164, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.079608v1
313/1/154    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, H.-l.
Right arrow Articles by Hollenberg, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, H.-l.
Right arrow Articles by Hollenberg, P. F.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5

Hsia-lien Lin, Ute M. Kent, and Paul F. Hollenberg

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan

Bergamottin (BG), a component of grapefruit juice, is a mechanism-based inactivator of cytochromes P450 (P450) 2B6 and 3A5 in the reconstituted system. The inactivation of both P450s was NADPH-dependent and irreversible. The kinetic constants for the inactivation of the 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of P450 2B6 were: KI, 5 µM; kinact 0.09 min–1; and t1/2, 8 min. The kinetic constants obtained for the inactivation of the testosterone 6{beta}-hydroxylation activity of P450 3A5 were: KI, 20 µM; kinact 0.045 min–1; and t1/2, 15 min. Incubations of P450s 2B6 and 3A5 with 20 µM BG at 37°C for 20 min resulted in an ~60% loss in the catalytic activity that was accompanied by a significant loss in intact heme and a similar decrease in the reduced CO difference spectrum. The extrapolated partition ratios for BG with P450s 2B6 and 3A5 were ~2 and ~20, respectively. Liquid chromatography-mass spectroscopy analysis of the BG-inactivated samples showed that the mass of the inactivated apoprotein had increased by approximately 388 Da for both P450 2B6 and P450 3A5. SDS-polyacrylamide gel electrophoresis analysis demonstrated that [14C]BG was irreversibly bound to the apoprotein in the BG-inactivated samples. The stoichiometry of binding was ~0.5 mol BG metabolite/mol of each P450 inactivated. High-pressure liquid chromatography analysis of the metabolites of BG showed that P450 2B6 generated two major metabolites, whereas P450 3A5 generated three additional metabolites. Two of metabolites were identified as 6',7'-dihydroxybergamottin and bergaptol.


Received October 21, 2004; accepted December 15, 2004.

Address correspondence to: Dr. Paul F. Hollenberg, Department of Pharmacology, 2301 MSRBIII, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0632. E-mail: phollen{at}umich.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. S. Kartha and G. S. Yost
Mechanism-Based Inactivation of Lung-Selective Cytochrome P450 CYP2F Enzymes
Drug Metab. Dispos., January 1, 2008; 36(1): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-l. Lin and P. F. Hollenberg
The Inactivation of Cytochrome P450 3A5 by 17{alpha}-Ethynylestradiol Is Cytochrome b5-Dependent: Metabolic Activation of the Ethynyl Moiety Leads to the Formation of Glutathione Conjugates, a Heme Adduct, and Covalent Binding to the Apoprotein
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 276 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
U. M. Kent, H.-l. Lin, K. R. Noon, D. L. Harris, and P. F. Hollenberg
Metabolism of Bergamottin by Cytochromes P450 2B6 and 3A5
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 992 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. N. Bumpus, U. M. Kent, and P. F. Hollenberg
Metabolism of Efavirenz and 8-Hydroxyefavirenz by P450 2B6 Leads to Inactivation by Two Distinct Mechanisms
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. N. Bumpus, C. Sridar, U. M. Kent, and P. F. Hollenberg
THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
Drug Metab. Dispos., June 1, 2005; 33(6): 795 - 802.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.